We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $751B
1-Year Est. Return 38.74%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+38.74%
3 Year Est. Return
+107.64%
5 Year Est. Return
+136.97%
10 Year Est. Return
+527.18%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,017
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.99%
2 Healthcare 13.12%
3 Financials 12.87%
4 Consumer Discretionary 9.34%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RZLT icon
3301
Rezolute
RZLT
$400M
$84K ﹤0.01%
+25,781
New +$85.7K
WEJO
3302
DELISTED
Wejo Group Limited Common Shares
WEJO
$84K ﹤0.01%
69,876
+50,427
+259% +$118K
PBYI icon
3303
Puma Biotechnology
PBYI
$477M
$83K ﹤0.01%
28,820
-46,174
-62% -$115K
EARN
3304
Ellington Residential Mortgage REIT
EARN
$156M
$81K ﹤0.01%
+10,721
New +$88.7K
HYPR icon
3305
Hyperfine
HYPR
$85M
$81K ﹤0.01%
36,085
TOON icon
3306
Kartoon Studios
TOON
$34.8M
$81K ﹤0.01%
10,629
-62,319
-85% -$477K
ANTX icon
3307
AN2 Therapeutics
ANTX
$202M
$79K ﹤0.01%
+10,189
New +$135K
CVGI icon
3308
Commercial Vehicle Group
CVGI
$121M
$79K ﹤0.01%
13,417
-71,794
-84% -$489K
INZY
3309
DELISTED
Inozyme Pharma
INZY
$79K ﹤0.01%
16,549
-13,948
-46% -$60.7K
RNAC icon
3310
Cartesian Therapeutics
RNAC
$239M
$79K ﹤0.01%
1,993
-6,017
-75% -$178K
ZY
3311
DELISTED
Zymergen Inc. Common Stock
ZY
$79K ﹤0.01%
64,144
-193,571
-75% -$325K
GTBP icon
3312
GT Biopharma
GTBP
$16.2M
$78K ﹤0.01%
34
-17
-33% -$32.2K
FSTX
3313
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$78K ﹤0.01%
+12,327
New +$41.5K
SHCO
3314
DELISTED
Soho House & Co
SHCO
$77K ﹤0.01%
11,814
HMPT
3315
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$77K ﹤0.01%
19,614
+3,996
+26% +$14.1K
AEHR icon
3316
Aehr Test Systems
AEHR
$2.66B
$76K ﹤0.01%
10,009
RVSB icon
3317
Riverview Bancorp
RVSB
$112M
$76K ﹤0.01%
11,437
ZOM
3318
DELISTED
Zomedica Corp.
ZOM
$76K ﹤0.01%
343,967
ANIX icon
3319
Anixa Biosciences
ANIX
$93.5M
$75K ﹤0.01%
+24,216
New +$76.4K
CVM icon
3320
CEL-SCI Corp
CVM
$26M
$75K ﹤0.01%
549
-2,611
-83% -$272K
IVAC
3321
DELISTED
Intevac Inc
IVAC
$75K ﹤0.01%
15,485
APYX icon
3322
Apyx Medical
APYX
$125M
$74K ﹤0.01%
12,488
-70,684
-85% -$363K
EPSN icon
3323
Epsilon Energy
EPSN
$187M
$74K ﹤0.01%
12,479
VYGR icon
3324
Voyager Therapeutics
VYGR
$190M
$74K ﹤0.01%
12,446
-3,464
-22% -$23.4K
OSG
3325
DELISTED
Overseas Shipholding Group Inc.
OSG
$74K ﹤0.01%
35,882

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,017 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.